IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 57
Titolo Data di pubblicazione Autore(i) File
Metabolic reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute lymphoblastic leukemia 1-gen-2016 Johnson, S. M.; Dempsey, C.; Chadwick, A.; Harrison, S.; Liu, J.; Di, Y.; Mcginn, O. J.; Fiorillo, M.; Sotgia, F.; Lisanti, M. P.; Parihar, M.; Krishnan, S.; Saha, V.
Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs) 1-gen-2016 Fiorillo, M; Lamb, R.; Tanowitz, Hb; Cappello, Anna Rita; Martinez Outschoorn, Ue; Sotgia, F; Lisanti, M. P.
Bergamot (Citrus bergamia Risso) Flavonoids and Their Potential Benefits in Human Hyperlipidemia and Atherosclerosis: an Overview. 1-gen-2016 Cappello, Ar; Dolce, V; Iacopetta, D; Martello, E; Fiorillo, M; Curcio, R; Muto, L; Dhanyalayam, Dhanya
New insights about the structural rearrangements required for substrate translocation in the bovine mitochondrial oxoglutarate carrier 1-gen-2016 Curcio, Rosita; Muto, L; Pierri, Cl; Montalto, A; Lauria, G; Onofrio, A; Fiorillo, M; Fiermonte, G; Lunetti, P; Vozza, A; Capobianco, L; Cappello, Anna Rita; Dolce, V.
Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics 1-gen-2017 Sotgia, F.; Fiorillo, M.; Lisanti, M. P.
Mitochondrial “power” drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer 1-gen-2017 Fiorillo, M; Sotgia, F; Sisci, Diego; Cappello, Anna Rita; Lisanti, M. P.
Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast 1-gen-2017 Ozsvari, Bela; Fiorillo, Marco; Bonuccelli, Gloria; Cappello, Anna Rita; Frattaruolo, Luca; Sotgia, Federica; Trowbridge, Rachel; Foster, Richard; Lisanti, Michael P.
In vitro antiproliferative and proapoptotic activities of 2-oxazolidinone derivatives 1-gen-2018 Mancuso, Raffaella; Armentano, Biagio; Frattaruolo, Luca; Brindisi, Matteo; Curcio, R.; Rago, Vittoria; Lappano, Rosamaria; Fiorillo, Marco; Dolce, Vincenza; Maggiolini, Marcello; Gabriele, Bartolo; Cappello, Anna Rita
Polyunsaturated Fatty Acids and their Role in the Diet of Cancer Patients: An Overview 1-gen-2018 Frattaruolo, L; Aiello, F; Carullo, G; Fiorillo, M; Brindisi, M; Cappello, Ms; Pilco, G; Cappello, Ar
The ER-alpha mutation Y537S confers Tamoxifen-resistance via enhanced mitochondrial metabolism, glycolysis and Rho-GDI/PTEN signaling: Implicating TIGAR in somatic resistance to endocrine therapy 1-gen-2018 Fiorillo, M.; Sanchez-Alvarez, R.; Sotgia, F.; Lisanti, M. P.
Bergamot natural products eradicate cancer stem cells (CSCs) by targeting mevalonate, Rho-GDI-signalling and mitochondrial metabolism 1-gen-2018 Fiorillo, M.; Peiris-Pagès, M.; Sanchez-Alvarez, R.; Bartella, L.; Di Donna, L.; Dolce, V.; Sindona, G.; Sotgia, F.; Cappello, A. R.; Lisanti, M. P.
Foxo3a re-expression overcomes tamoxifen resistance in breast cancer 1-gen-2018 Morelli, C; Fiorillo, M; Pellegrino, M; Rizza, P; Nigro, A; Ricci, E; Lanzino, M; Sisci, D
A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX 1-gen-2018 Sotgia, F.; Ozsvari, B.; Fiorillo, M.; De Francesco, E. M.; Bonuccelli, G.; Lisanti, M. P.
ERRα PATHWAY AND ENDOCRINE RESISTANCE ON BREAST CANCER: CHOLESTEROL AND MEVALONATE INVOLVEMENT 1-gen-2019 Brindisi, M.; Fiorillo, M.; Frattaruolo, L.; Curcio, R.; Dolce, V.; Sotgia, F.; Lisanti, M. P.; Cappello, A. R.
GENOMICS-BASED DISCOVERY AND ANTICANCER ACTIVITY ASSESSMENT OF NEW THIOVIRIDAMIDE-LIKE MOLECULES PRODUCED BY ACTINOBACTERIA 1-gen-2019 Frattaruolo, L.; Fiorillo, M.; Brindisi, M.; Lacret, R.; Curcio, R.; Dolce, V.; Truman, A. W.; Sotgia, F.; Lisanti, M. P.; Cappello, A. R.
Hallmarks of the cancer cell of origin: Comparisons with "energetic" cancer stem cells (e-CSCs) 1-gen-2019 Sotgia, F.; Fiorillo, M.; Lisanti, M. P.
"Energetic" cancer stem cells (e-CSCs): A new hyper-metabolic and proliferative tumor cell phenotype, driven by mitochondrial energy 1-gen-2019 Fiorillo, M.; Sotgia, F.; Lisanti, M. P.
Doxycycline, Azithromycin and vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs) 1-gen-2019 Fiorillo, M.; Toth, F.; Sotgia, F.; Lisanti, M. P.
FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer 1-gen-2019 Pellegrino, Michele; Rizza, Pietro; Donà, Ada; Nigro, Alessandra; Ricci, Elena; Fiorillo, Marco; Perrotta, Ida; Lanzino, Marilena; Giordano, Cinzia; Bonofiglio, Daniela; Bruno, Rosalinda; Sotgia, Federica; Lisanti, Michael P; Sisci, Diego; Morelli, Catia
Thioalbamide, A Thioamidated Peptide from Amycolatopsis alba, Affects Tumor Growth and Stemness by Inducing Metabolic Dysfunction and Oxidative Stress 1-gen-2019 Frattaruolo, Luca; Fiorillo, Marco; Brindisi, Matteo; Curcio, Rosita; Dolce, Vincenza; Lacret, Rodney; Truman, Andrew W; Sotgia, Federica; Lisanti, Michael P; Cappello, Anna Rita
Mostrati risultati da 21 a 40 di 57
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile